Showing results (41-50 of 179) with videos related to
Sort By:
Pageof 18
Clinical Lung Cancer|February 25, 2024
HER2-Mutant Advanced and/or Metastatic Non-Small-Cell Lung Cancer: A US Electronic Health Records Database Analysis of Clinical Characteristics, Treatment Practice Patterns, and OutcomesSarah Waliany, Joel W Neal, Nicole Engel-Nitz, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 4, 2021
Role of Consolidation Durvalumab in Patients With EGFR- and HER2-Mutant Unresectable Stage III NSCLCJessica A Hellyer, Jacqueline V Aredo, Millie Das, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 8, 2017
ERBB2-Mutated Metastatic Non-Small Cell Lung Cancer: Response and Resistance to Targeted TherapiesJody C Chuang, Henning Stehr, Ying Liang, et al.Clinical Lung Cancer|November 17, 2018
Natural Disease History, Outcomes, and Co-mutations in a Series of Patients With BRAF-Mutated Non-small-cell Lung CancerNathaniel J Myall, Solomon Henry, Douglas Wood, et al.Clinical Lung Cancer|February 15, 2014
Prolonged survival of patients with non-small-cell lung cancer with leptomeningeal carcinomatosis in the modern treatment eraJonathan W Riess, Seema Nagpal, Michael Iv, et al.Lung Cancer (Amsterdam, Netherlands)|July 20, 2019
Impact of KEAP1/NFE2L2/CUL3 mutations on duration of response to EGFR tyrosine kinase inhibitors in EGFR mutated non-small cell lung cancerJessica A Hellyer, Henning Stehr, Millie Das, et al.Clinical Lung Cancer|August 15, 2021
EGFR exon 20 Insertion NSCLC and Response to Platinum-Based ChemotherapyManan P Shah, Jacqueline V Aredo, Sukhmani K Padda, et al.Clinical Lung Cancer|February 19, 2019
Increased Galectin-1 Expression in Thymic Epithelial TumorsJonathan W Riess, Christina S Kong, Robert B West, et al.Lung Cancer (Amsterdam, Netherlands)|June 16, 2019
Impact of KRAS mutation subtype and concurrent pathogenic mutations on non-small cell lung cancer outcomesJacqueline V Aredo, Sukhmani K Padda, Christian A Kunder, et al.Clinical Lung Cancer|June 26, 2022
Characterization of ERBB2 (HER2) Alterations in Metastatic Non-small Cell Lung Cancer and Comparison of Outcomes of Different Trastuzumab-based RegimensSarah Waliany, Heather Wakelee, Kavitha Ramchandran, et al.Pageof 18